ORAL SUBSTITUTION IN PATIENTS SENSITIZED BY TRANSDERMAL CLONIDINE TREATMENT

[1] BOEKHORST JC, 1983, LANCET, V2, P1031

[2] CONTACT-DERMATITIS .17. REACTIONS TO CONTACT ALLERGENS GIVEN ORALLY OR SYSTEMICALLY [J]. BRITISH JOURNAL OF DERMATOLOGY, 1972, 86 (01) : 104 - +

[3] CRONIN E, 1980, CONTACT DERMATITIS, P279

[4] DOMONKOS AN, 1982, ANDREWS DISEASE SKIN, P97

[5] EKELUND AG, 1969, ACTA DERM-VENEREOL, V49, P422

[6] CONTACT ECZEMA PRODUCED BY A BETA-ADRENERGIC BLOCKING-AGENT (ALPRENOLOL) [J]. CONTACT DERMATITIS, 1978, 4 (04) : 190 - 194

[7] FISHER AA, 1984, CUTIS, V33, P530

[8] FISHER AA, 1984, CUTIS, V34, P526

[9] FISHER AA, 1967, CONTACT DERMATITIS, P231

[10] GOODMAN LS, 1980, PHARMACOL BASIS THER, P797

[1] BOEKHORST JC, 1983, LANCET, V2, P1031

[2] CONTACT-DERMATITIS .17. REACTIONS TO CONTACT ALLERGENS GIVEN ORALLY OR SYSTEMICALLY [J]. BRITISH JOURNAL OF DERMATOLOGY, 1972, 86 (01) : 104 - +

[3] CRONIN E, 1980, CONTACT DERMATITIS, P279

[4] DOMONKOS AN, 1982, ANDREWS DISEASE SKIN, P97

[5] EKELUND AG, 1969, ACTA DERM-VENEREOL, V49, P422

[6] CONTACT ECZEMA PRODUCED BY A BETA-ADRENERGIC BLOCKING-AGENT (ALPRENOLOL) [J]. CONTACT DERMATITIS, 1978, 4 (04) : 190 - 194

[7] FISHER AA, 1984, CUTIS, V33, P530

[8] FISHER AA, 1984, CUTIS, V34, P526

[9] FISHER AA, 1967, CONTACT DERMATITIS, P231

[10] GOODMAN LS, 1980, PHARMACOL BASIS THER, P797